JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neilipovitz, D. T.
Right arrow Articles by Nichol, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neilipovitz, D. T.
Right arrow Articles by Nichol, G.
Related Collections
Right arrow Blood
Right arrow Cardiovascular
Anesth Analg 2001;93:573-580
© 2001 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

The Effect of Perioperative Aspirin Therapy in Peripheral Vascular Surgery: A Decision Analysis

David T. Neilipovitz, FRCPC*, Gregory L. Bryson, MSc, FRCPC*{dagger}, and Graham Nichol, MPH, FRCPC{dagger}{ddagger}

Departments of *Anesthesiology and {ddagger}Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada; and the {dagger}Clinical Epidemiology Unit, Loeb Medical Research Institute, Ottawa, Ontario, Canada

Address correspondence and reprint requests to Dr. David T. Neilipovitz, Department of Anesthesiology, The Ottawa Hospital—Civic Campus, 1053 Carling Ave., Ottawa, Ontario K1Y 4E9. Address e-mail to dneilipovitz{at}ottawahospital.on.ca

Patients who undergo infrainguinal revascularization surgery are at increased risk for perioperative thrombotic complications. Aspirin decreases thrombotic events in the nonoperative setting; however, aspirin is often discontinued to avoid perioperative hemorrhagic complications. We used a decision analysis to determine whether aspirin should be discontinued before infrainguinal revascularization surgery. Two strategies were compared: aspirin cessation 2 wk before surgery and aspirin continuation throughout the perioperative period. Clinical events examined included myocardial infarction, thrombotic cerebrovascular accident, hemorrhagic cerebrovascular accident, gastrointestinal hemorrhage, and incisional hemorrhagic complications. Event rates and effect of aspirin were obtained by using MEDLINE. The outcomes were perioperative mortality, life expectancy, and quality-adjusted life expectancy. According to the model, continued aspirin use decreased perioperative mortality rates from 2.78% to 2.05%. Continued aspirin use increased life expectancy from 14.83 to 14.89 yr and increased quality-adjusted life expectancy from 14.72 to 14.79 yr. Aspirin increased the number of hemorrhagic complications by 2.46%, primarily because of an increased incidence of non-life-threatening complications.

IMPLICATIONS: Decision analysis indicates that continued aspirin use in patients undergoing infrainguinal revascularization surgery is associated with a decreased perioperative mortality and increased life expectancy but may increase the likelihood of minor hemorrhagic complications.




This article has been cited by other articles:


Home page
 Eur Heart J SupplHome page
M. E. Bertrand
When and how to discontinue antiplatelet therapy
Eur. Heart J. Suppl., January 1, 2008; 10(suppl_A): A35 - A41.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
T. Lecompte and J.-F. Hardy
Antiplatelet agents and perioperative bleeding: [Les inhibiteurs plaquettaires et le saignement perioperatoire].
Can J Anesth, June 1, 2006; 53(6_suppl): S103 - S112.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. Marret, J.-P. Collet, P. Albaladejo, and G. Montalescot
Thrombosis After Implantation of Drug-Eluting Stents
JAMA, January 4, 2006; 295(1): 36 - 36.
[Full Text] [PDF]

Home page
 CirculationHome page
J.P. Collet, G. Montalescot, B. Blanchet, M.L. Tanguy, J.L. Golmard, R. Choussat, F. Beygui, L. Payot, N. Vignolles, J.P. Metzger, et al.
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
Circulation, October 19, 2004; 110(16): 2361 - 2367.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. E. Newby and A. F. Nimmo
Editorial II: Prevention of cardiac complications of non-cardiac surgery: stenosis and thrombosis
Br. J. Anaesth., May 1, 2004; 92(5): 628 - 632.
[Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
P. J. S. Koo
Acute Pain Management
Journal of Pharmacy Practice, August 1, 2003; 16(4): 231 - 248.
[Abstract] [PDF]

Home page
 NEJMHome page
R. Ehlers, T. W. Felbinger, H. K. Eltzschig, L. A. Fleisher, and K. A. Eagle
Lowering Cardiac Risk in Noncardiac Surgery
N. Engl. J. Med., April 4, 2002; 346(14): 1096 - 1097.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.